Background: Use of antispasmodic medication prior to colonoscopy is co
ntroversial but may improve visualization of colonic mucosa and ease c
olonoscope insertion. Method: The effects on the performance of colono
scopy by premedication with the antispasmodic hyoscine n-butyl bromide
were studied in a prospective, double-blind, placebo-controlled trial
. Fifty-six consecutive patients were randomly assigned to receive int
ravenous hyoscine 20 mg (n = 29) or placebo (n = 27) in conjunction wi
th our standard initial medications (meperidine 0.7 mg/kg and midazola
m 0.03 mg/kg). Insertion and withdrawal of the colonoscope were timed,
and 100 mm visual analogue scales were used to assess procedure diffi
culty, colonic motility, and the degree of discomfort experienced by t
he patients. Results: In those patients receiving hyoscine, intubation
time was quicker (median hyoscine, 13 minutes; median placebo, 17.5 m
inutes, p = 0.045) and colonic spasm less (median hyoscine, 19 mm; med
ian placebo, 53.5 mm, p = 0.01). The procedure was considered signific
antly less difficult in the hyoscine group (median, 23.5 mm) compared
to the placebo group (median, 50), p < 0.05. No significant difference
s in withdrawal time or patient pain scores were found. Conclusions: P
remedication with intravenous hyoscine n-butyl bromide reduces colonic
spasm and in this study made colonoscope insertion significantly quic
ker and easier.